Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

April 30, 2024

https://www.globenewswire.com/news-release/2024/04/30/2872507/0/en/Transforming-Cancer-Detection-RenovaroCube-Introduces-Flamingo-a-novel-AI-model-based-on-Fragmentomics.html

LOS ANGELES and AMSTERDAM, April 30, 2024 (GLOBE NEWSWIRE) — RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (Nasdaq:RENB), a company at the forefront of AI-driven healthcare innovation, proudly unveils Flamingo, a potentially groundbreaking multi-cancer detection model contributing to its mission to transform early cancer diagnostics. Leveraging ultra-low pass whole genome sequencing (ULP-WGS) of cell-free DNA (cfDNA), Flamingo represents a promising leap forward in the fight against cancer.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.